MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 290 filers reported holding MIRATI THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,383,000 | +20.2% | 7,818 | +9.7% | 0.00% | +33.3% |
| Q2 2021 | $1,151,000 | +6.5% | 7,126 | +12.9% | 0.00% | -25.0% |
| Q1 2021 | $1,081,000 | -15.9% | 6,310 | +7.8% | 0.00% | -20.0% |
| Q4 2020 | $1,285,000 | +83.0% | 5,851 | +38.4% | 0.01% | +66.7% |
| Q3 2020 | $702,000 | -6.1% | 4,227 | -35.5% | 0.00% | -40.0% |
| Q2 2020 | $748,000 | +70.4% | 6,549 | +14.7% | 0.01% | +66.7% |
| Q1 2020 | $439,000 | -24.3% | 5,710 | +26.9% | 0.00% | -25.0% |
| Q4 2019 | $580,000 | +71.6% | 4,499 | +3.8% | 0.00% | +100.0% |
| Q3 2019 | $338,000 | – | 4,336 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $116,595,216 | 81.37% |
| ORACLE INVESTMENT MANAGEMENT INC | 201,400 | $7,488,052 | 7.25% |
| Paradigm Biocapital Advisors LP | 1,396,779 | $51,932,243 | 4.92% |
| Octagon Capital Advisors LP | 750,000 | $27,885,000 | 4.01% |
| Boxer Capital, LLC | 2,000,000 | $74,360 | 3.65% |
| Artal Group S.A. | 1,537,709 | $57,172 | 3.40% |
| Avoro Capital Advisors LLC | 5,555,555 | $206,555,535 | 3.06% |
| RTW INVESTMENTS, LP | 3,643,114 | $135,450,979 | 2.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 244,000 | $9,071,920 | 2.53% |
| Kynam Capital Management, LP | 499,853 | $18,584,535 | 2.40% |